AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain

RecruitingEARLY Phase 1Ages 18 Years - 80 YearsAllQinghai Red Cross Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This trial aims to address refractory cancer pain (RCP). It will explore the synergistic efficacy and safety of hydromorphone hydrochloride sustained-release tablets (HHST) combined with electroacupuncture (EA) and ear acupoint pressing beans (EAPB) for RCP. Key outcomes will include dynamic changes in Numerical Rating Scale (NRS) scores, proportions of patients with effective analgesia (โ‰ฅ30% NRS reduction from baseline) and marked remission (โ‰ฅ50% NRS reduction from baseline), daily HHST dosage, breakthrough pain (BP) frequency, and drug-related adverse events (AEs) graded by CTCAE 6.0.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patients who meet the diagnostic criteria for cancer ; 2. Diagnosis of refractory cancer pain; 3. Aged 18 or 80 years; 4. Expected survival period โ‰ฅ3 months; 5. Karnofsky Performance Status (KPS) score โ‰ฅ30 and Quality of Life (QOL) score โ‰ฅ20; 6. No history of allergy to opioid analgesics; 7. No intellectual or psychiatric disorders; normal comprehension ability,capable of cooperating with pain assessments and questionnaire completion; 8. Provision of signed written informed consent. Exclusion Criteria: 1. Patients with pain clearly unrelated to the tumor itself; 2. Patients with pain relief after standardized pharmacological treatment; 3. Patients aged under 18 years or over 80 years; 4. Patients with an expected survival of less than 3 months; 5. Patients with a Karnofsky Performance Status (KPS) score \< 30 or Quality of Life (QOL) score \< 20; 6. Pregnant or lactating women; 7. Patients with intellectual disability, mental or consciousness disturbance, who are unable to assess pain accurately or complete questionnaire surveys; 8. Patients with needle phobia or extreme resistance to acupuncture treatment; 9. Patients with hypersensitivity to Semen Vaccariae (Wang Bu Liu Xing).
๐Ÿ’Š

What it tests

  • Hydromorphone Hydrochloride Extended-Release Tablets
  • Electroacupuncture
  • Ear Acupoint Pressing Beans
๐Ÿ“

Where

1 site
Qinghai Red Cross Hospital
Xining, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy